Drug Testing for the DOC Toxicology Lab - DOC

The State of Missouri Department of Corrections (DOC) is soliciting proposals for comprehensive drug testing services for its Toxicology Laboratory located in Fulton, Missouri, covering urine and oral fluid testing for various controlled substances. The procurement seeks vendors capable of providing drug testing for substances including THC, cocaine, PCP, opiates, benzodiazepines, amphetamines, EtG, fentanyl, and Suboxone, as well as adulterant testing for creatinine, specific gravity, oxidants, and pH. The contract will cover significant testing volumes, with estimated quantities ranging from 2 to 73,677 tests per substance type, totaling approximately 335,000 tests annually. A pre-proposal teleconference is scheduled for April 5, 2024, at 1:00 PM Central Time, and potential vendors may schedule tours of the DOC Toxicology Laboratory prior to submitting proposals. Proposals are due by April 16, 2024, at 2:00 PM CDT, with the initial contract period running from the date of award through December 31, 2024. Vendors must provide pricing for the initial contract period and up to four potential renewal periods, along with a firm, fixed percentage discount to be applied to their price list or catalog.

The solicitation appears to be open to all vendors, with no specific set-aside designations or restrictions on respondent types mentioned in the documentation. No incumbent vendor information is provided, and there are no explicit requirements regarding disadvantaged enterprise participation. Payment terms are established at Net 45 days, with delivery specified as FOB Destination to the DOC Toxicology Laboratory in Fulton. While a specific total contract value is not disclosed, the estimated annual testing volume suggests a substantial procurement opportunity. The contract will be awarded to the lowest and best responsive, responsible bidder, with funding to be provided by the State of Missouri. Vendors will be required to comply with Business Associate Provisions and submit sample laboratory reports as part of their proposal. The successful vendor will be expected to provide high-quality, accurate drug testing services to support the DOC's operational needs, with potential for up to four one-year renewal periods following the initial contract term.